Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Lee Jae-Myung
Artificial Intelligence
Social Media
Natural Disasters
Senate
Baseball
Donald Trump
Education
Stock Markets
Wildfires
Immigration
Innovation
Published • loading... • Updated

HER3-DXd Does Not Yield Improved OS in EGFR-Mutated NSCLC

Summary by cancernetwork.com
Results from HERTHENA-Lung02 did not show improved OS with HER3-DXd for patients with EGFR-mutated NSCLC.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
cancernetwork.comcancernetwork.com

HER3-DXd Does Not Yield Improved OS in EGFR-Mutated NSCLC

Results from HERTHENA-Lung02 did not show improved OS with HER3-DXd for patients with EGFR-mutated NSCLC.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

cancernetwork.com broke the news in on Sunday, June 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal